Totals
- Total revenue
- $160,274
- Total expenses
- $1,088,668
- Contributions and grants received
- $0
- Grants paid
- $0
- Program service revenue
- $0
- Investment income
- $160,274
- Other revenue
- $0
- Total assets, end of year
- $10,413,108
- Total liabilities, end of year
- $302
- Net assets or fund balances, end of year
- $10,412,806
- Program services expenses (Part IX)
- $1,047,775
- Management and general expenses
- $40,893
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $1,047,775
Program services were 96.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
3 · Investment income
total $160,274 · excluded $160,274
Functional expenses
Part IX, the statement of functional expenses.
-
11a · Fees: management
total $991,877 · program services $991,877
-
11b · Fees: legal
total $12,671 · management and general $12,671
-
11c · Fees: accounting
total $11,190 · management and general $11,190
-
13 · Office expenses
total $15,356 · management and general $15,356
-
16 · Occupancy
total $1,478 · management and general $1,478
-
19 · Conferences, conventions and meetings
total $198 · management and general $198
-
23 · Insurance
total $55,898 · program services $55,898
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $9,659,928 · end of year $9,776,890
-
4 · Accounts receivable
end of year $1,373
-
9 · Prepaid expenses and deferred charges
beginning of year $1,682,620 · end of year $634,845
-
17 · Accounts payable and accrued expenses
beginning of year $1,046
-
25 · Other liabilities
beginning of year $302 · end of year $302
-
29 · Capital stock, trust principal or current funds
beginning of year $0 · end of year $0
-
30 · Paid-in or capital surplus, or land, building or equipment fund
beginning of year $0 · end of year $0
-
31 · Retained earnings, endowment or other funds
beginning of year $11,341,200 · end of year $10,412,806
Mission and programs · 2023
Mission
TO PROVIDE SUPPORT FOR DEVELOPMENTALLY DISABLED POPULATION.
-
THE ORGANIZATION PREVIOUSLY SOLD THE CONTRACT FOR OPERATIONS OF THE FACILITIES. SUBJECT TO THE STATUTE OF LIMITATIONS OF LEGAL ACTIVITY, THE BOARD OF DIRECTORS PAID FOR FOUR YEARS OF WRAP UP SERVICES AND AMORTIZED THE AMOUNT OVER A 48 MONTH PERIOD, REPORTED AS THE QUEST MANAGEMENT FEES. ONCE THE REMAINING LEGAL CONCERNS ARE RESOLVED, THE BOARD OF DIRECTORS WILL VOTE ON WHETHER TO DISSOLVE AND LIQUIDATE OR CONTINUE OPERATIONS IN SUPPORT OF THE DEVELOPMENTALLY DISABLED POPULATION.
Expenses $1,047,775
As filed on the 2023 return.
Listed in Part VII
-
ELIZABETH M WERRE
PRESIDENT
- Total calculated
- $0
- Hours/week
- 2
-
WR ARMSTRONG
SECRETARY/TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
ROSEANNA PHILLIPS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
DELLA MERRITT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
GUY FARMER
VICE PRESIDENT
- Total calculated
- $0
- Hours/week
- 2
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 17 September 2024
- IRS schema version
- 2023v5.1
- Source object
- 202402689349300510
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.